Atlas Trials

Clinical and Sociodemographic Characterization of Multiple Myeloma Participants With Symptomatic Relapse and/or Refractory Disease in Spain (CharisMMa Study)

Clinical trial NCT03188536 · COMPLETED

Trial details

NCT number
NCT03188536
Sponsor
Takeda
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple Myeloma
Start date
2017-07-26
Primary completion
2018-11-15
Enrollment
282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.